PT - JOURNAL ARTICLE AU - Malucelli, Lucca Centa AU - Alves, Gabriele Luise Neves AU - dos Santos, Carolina Melchioretto AU - Severo, Matheus Gonçalves AU - Ribeiro, Victor Henrique Alves AU - de Almeida, Bernardo Montesanti Machado AU - Klosovski, Caio Corsi AU - Martinez, Tania Leme da Rocha AU - Scartezini, Marileia AU - Figueredo, Marcus Vinícius Mazega TI - Validation of a Novel IoT and AI based Point-of-Care Testing Laboratory: Analytical Accuracy and Clinical Agreement AID - 10.1101/2021.10.29.21264864 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.29.21264864 4099 - http://medrxiv.org/content/early/2021/10/30/2021.10.29.21264864.short 4100 - http://medrxiv.org/content/early/2021/10/30/2021.10.29.21264864.full AB - Point-of-care testing (POCT) offers several advantages over traditional laboratory testing. Offering less invasive testing with a faster turnaround time is not enough if not associated with an acceptable level of accuracy. Here, we show the analytical validation behind the multi-analyte POCT immunochromatography analyser, Hilab Flow (HiF). Analyses from 4,518 clinical samples were compared to College of American Pathologists accredited laboratories for ten quantitative and thirteen qualitative exams. Compatibility between methods was evaluated in terms of association/correlation and clinical agreement. Strong correlation/ concordance was observed between quantitative (CHOL, HDL-c, TG, HbA1c, Glycemia, 25-Hydroxy Vitamin D, TSH, Uric Acid, Creatinine, Urea) and qualitative methods (COVID-19 IgG/ IgM, Beta-hCG, Syphilis, Anti-HBsAg, Zika IgG/ IgM, Influenza A/B, HIV, HCV, HBsAg, Dengue NS1, COVID-19 Ag, Dengue IgG/ IgM, PSA). Approval criteria was obtaining a kappa agreement > 0.8 or a Pearson correlation > 0.9 depending on the exam. Overall percentage agreement was greater than 95% for all exams, indicating a good clinical agreement to gold-standard laboratory-based tests. Results indicate all exams are suitable for POCT and present a reliable performance. Data support the analyser is a useful tool to aid decision-making at the clinical setting, with potential to contribute with healthcare solutions in diagnostic medicine worldwide.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Hilab Laboratory.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Internal data from the routine analysis of clinical laboratory service were used retrospectively for this in-house validation study. The study was approved by the Beneficencia Portuguesa Research Ethics Committee: CAEE 33490420.9.0000.5483.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.